This guide is intended for use by the researchers at Rutgers University on compliance with federal funding agencies public access policies, focusing on NIH Public Access Policy (PAP). The content of this guide is outlined below:
- Submission Methods
- Citing PMCID
NIH Public Access Policy requires:
Failure to comply with the NIH Public Access Policy could result in discontinuation of funding or no future funding.
Rutgers University Libraries provide support for NIH Public Access Policy compliance and assistance to authors who have questions about the policy or need assistance in finding publisher policies, submission methods, PMCID numbers, or other information. Email to: firstname.lastname@example.org for additional information, questions, and support.
Posted on January 26, 2016
NIH Adjusts Salary Cap for Grants, Cooperative Agreements, and Contracts
"For FY 2016, the Consolidated Appropriations Act, 2016 (Public Law 114-113), signed into law on December 18, 2015, restricts the amount of direct salary to Executive Level II of the Federal Executive pay scale. The Executive Level II salary is currently set at $183,300, increasing to $185,100 effective January 10, 2016." To view the complete NIH Notice. click here.
Posted on April 14, 2015
For Rutgers Researchers: NIH Proposals - RAPSS Use (Mandatory Starting April 29)
April 29 is the go-live date for the new Rutgers Research Administration and Proposal Submission System (RAPSS). [RAPSS initially will be used only for new NIH proposals; it cannot be used for non-competing continuations, supplements, etc.].
Mandatory: All proposals for new NIH grants, beginning with those due June 5 must be submitted via RAPSS.
Recommended: Everyone intending to submit a new NIH proposal due June 5 should attend a RAPSS training session.
NEW: additional training sessions added in May on all three campuses. More information on training schedule is available at: https://ored.rutgers.edu/rapss/training-sessions.
Posted on March 11, 2015
On March 11, 2015, NPR All Things Considered aired a piece of news that according to a study in this week's NEJM (N Engl J Med 2015; 372:1031-1039 March 12, 2015, DOI: 10.1056/NEJMsa1409364), many scientistis failed to report results to ClinicalTrials.gov in a timely fashion during the study period, as required by FDAAA 801 (Section 801 of the Food and Drug Administration Amendments act). To listen to this piece from All Things Considered, click here.
Rutgers is an equal access/equal opportunity institution. Individuals with disabilities are encouraged to direct suggestions, comments, or complaints concerning any accessibility issues with Rutgers websites to email@example.com or complete the Report Accessibility Barrier / Provide Feedback form.